← Aon overview

Aon vs Marsh & McLennan Companies: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Aon PLC (AON)

Q3 2026
▲3▼1

Aon's $17B USI Deal Pressures Stock Despite Solid Q2

  • USI Acquisition and Debt Concerns Aon agreed to buy USI Insurance Services for $17 billion in an all-debt deal, adding about $3 billion in revenue and strengthening its U.S. middle-market and specialty business. The rich price, new debt, and paused buybacks pushed the stock down 7–10.5%.

    This is the main event of the period and explains the stock's decline.

  • Strong Q2 2026 Results Aon reported 5% organic growth, 9% higher adjusted earnings per share, and expanding profit margins in Q2 2026. These results show the core business remains healthy and profitable.

    This provides a positive counterweight to the acquisition concerns and shows underlying strength.

  • New Growth Initiatives Aon launched new programs like Data Center Lifecycle, Sidecar X, and Power Lifecycle, and consolidated its Totalis Specialty Group. These moves aim to capture demand in fast-growing areas and support future revenue.

    These initiatives signal forward-looking growth opportunities that could offset acquisition risks.

  • Rising Health Costs to Boost Revenue A forecast 9.5% rise in 2027 health costs is expected to increase demand for Aon's advisory and brokerage services, potentially driving higher revenue. However, flawless integration of USI and steady debt reduction remain essential.

    This highlights a favorable industry trend that could benefit Aon, while noting execution risks.

August 2026
▲3▼1

Aon's $17B USI Deal Pressures Stock Despite Solid Q2

  • USI Acquisition and Debt Concerns Aon agreed to buy USI Insurance Services for $17 billion in an all-debt deal, adding about $3 billion in revenue and strengthening its U.S. middle-market and specialty business. The rich price, new debt, and paused buybacks pushed the stock down 7–10.5%.

    This is the main event of the period and explains the stock's decline.

  • Strong Q2 2026 Results Aon reported 5% organic growth, 9% higher adjusted earnings per share, and expanding profit margins in Q2 2026. These results show the core business remains healthy and profitable.

    This provides a positive counterweight to the acquisition concerns and shows underlying strength.

  • New Growth Initiatives Aon launched new programs like Data Center Lifecycle, Sidecar X, and Power Lifecycle, and consolidated its Totalis Specialty Group. These moves aim to capture demand in fast-growing areas and support future revenue.

    These initiatives signal forward-looking growth opportunities that could offset acquisition risks.

  • Rising Health Costs to Boost Revenue A forecast 9.5% rise in 2027 health costs is expected to increase demand for Aon's advisory and brokerage services, potentially driving higher revenue. However, flawless integration of USI and steady debt reduction remain essential.

    This highlights a favorable industry trend that could benefit Aon, while noting execution risks.

Latest
▲3▼1

Aon's $17B USI deal reshapes growth, debt, and buybacks

  • USI acquisition funded with debt pressures stock Aon confirmed a $17 billion all-cash purchase of USI Insurance Services, funded entirely with new debt. This means no near-term share buybacks as Aon prioritizes debt repayment. The stock fell 10.5% in August on this news, as investors worry about added debt and paused buybacks.

    This is the biggest new event driving AON's price, explaining the recent drop and shift in capital priorities.

  • Strong Q2 results show resilient growth Aon reported 5% organic revenue growth and 9% higher adjusted earnings per share in Q2 2026, with margins expanding. All business lines grew mid-single digits. This shows the core business is healthy and supports the stock price despite acquisition concerns.

    Q2 results are a key new data point confirming Aon's underlying business strength.

  • New insurance programs expand capacity and demand Aon launched several new programs: Data Center Lifecycle Insurance expanded to $5 billion, Sidecar X with $200 million for M&A risk, and Power Lifecycle Program with up to $2.5 billion per project. These broaden Aon's offerings and should drive revenue growth.

    These new products show Aon's innovation and ability to capture demand in growing sectors like data centers and energy.

  • Specialty consolidation and health cost forecast boost outlook Aon is combining specialty businesses into Totalis Specialty Group, overseeing over $5.5 billion in US premium. Also, Aon forecasts a 9.5% rise in 2027 employer health costs, which should increase demand for its health consulting services. Both support future revenue growth.

    These moves strengthen Aon's specialty and health consulting platforms, key growth areas.

▲1▼1

Aon's $17B USI Deal: Growth Bet, Debt and Buyback Pause

  • Debt-funded USI deal and buyback pause sink shares Aon agreed to buy USI Insurance Services for $17 billion, funded entirely with new debt. It will pause share buybacks to repay debt, and the stock fell about 7% as investors worried about the added financial burden and near-term shareholder returns.

    This is the core new event that directly drove AON's sharp price drop this period.

  • USI expands middle-market and specialty reach USI adds about $3 billion in annual revenue, 10,500 employees, and nearly 200 offices, strengthening Aon's U.S. middle-market and excess-and-surplus insurance business. Management expects $395 million in annual cost and revenue benefits, with earnings accretion starting in 2028.

    Explains the strategic upside that could support AON's price longer term despite the negative reaction.

  • High price tag leaves little room for error Aon is paying about 14.5 times synergized trailing earnings for USI, a rich valuation that demands flawless integration. If Aon delivers the planned savings and cuts debt steadily, the deal could create lasting value; if not, the stock may stay under pressure.

    Gives the fair counterweight: the deal is strategically strong but financially demanding, which explains the mixed market reaction.

Marsh & McLennan Companies, Inc. (MRSH)

Q3 2026
▲3

Marsh grows on health-cost demand, buybacks, AI push despite falling insurance rates

  • Q2 beat, buybacks and 10% dividend hike Marsh reported 6% revenue growth and 9% higher adjusted EPS, bought back $750 million of stock and raised its dividend 10% for a 17th straight year. Steady profit and cash returned to shareholders support the share price.

    The quarter's results and capital returns are the core new financial facts driving the stock.

  • Health-cost surge lifts benefits consulting demand Marsh's survey projects US employer health costs will jump 8.2% in 2027, the steepest since 2003. Rising costs push employers to seek Marsh's benefits advice, supporting demand for its consulting business and its revenue outlook.

    This is the period's biggest demand driver for Marsh's consulting arm.

  • Falling insurance rates offset by AI and new services Commercial insurance rates fell 6% and property rates 12%, a headwind to brokerage commissions. Marsh is countering with AI tools like Risk Companion and new offerings such as Archer, which add recurring service revenue and broaden its mix.

    It captures the main negative force on pricing and the company's response.

  • Analysts see 2026 earnings up 7.1% Zacks notes rising 2026 earnings estimates, a $5.5 billion capital deployment plan and management consulting growing 13.4% organically, its fastest in over two years. Upward revisions and expected Q3 beat support the stock.

    Analyst estimate momentum and capital plans are a key forward-looking driver.

August 2026
▲3

Marsh grows on health-cost demand, buybacks, AI push despite falling insurance rates

  • Q2 beat, buybacks and 10% dividend hike Marsh reported 6% revenue growth and 9% higher adjusted EPS, bought back $750 million of stock and raised its dividend 10% for a 17th straight year. Steady profit and cash returned to shareholders support the share price.

    The quarter's results and capital returns are the core new financial facts driving the stock.

  • Health-cost surge lifts benefits consulting demand Marsh's survey projects US employer health costs will jump 8.2% in 2027, the steepest since 2003. Rising costs push employers to seek Marsh's benefits advice, supporting demand for its consulting business and its revenue outlook.

    This is the period's biggest demand driver for Marsh's consulting arm.

  • Falling insurance rates offset by AI and new services Commercial insurance rates fell 6% and property rates 12%, a headwind to brokerage commissions. Marsh is countering with AI tools like Risk Companion and new offerings such as Archer, which add recurring service revenue and broaden its mix.

    It captures the main negative force on pricing and the company's response.

  • Analysts see 2026 earnings up 7.1% Zacks notes rising 2026 earnings estimates, a $5.5 billion capital deployment plan and management consulting growing 13.4% organically, its fastest in over two years. Upward revisions and expected Q3 beat support the stock.

    Analyst estimate momentum and capital plans are a key forward-looking driver.

Latest
▲3

Marsh grows on health-cost demand, buybacks, AI push despite falling insurance rates

  • Q2 beat, buybacks and 10% dividend hike Marsh reported 6% revenue growth and 9% higher adjusted EPS, bought back $750 million of stock and raised its dividend 10% for a 17th straight year. Steady profit and cash returned to shareholders support the share price.

    The quarter's results and capital returns are the core new financial facts driving the stock.

  • Health-cost surge lifts benefits consulting demand Marsh's survey projects US employer health costs will jump 8.2% in 2027, the steepest since 2003. Rising costs push employers to seek Marsh's benefits advice, supporting demand for its consulting business and its revenue outlook.

    This is the period's biggest demand driver for Marsh's consulting arm.

  • Falling insurance rates offset by AI and new services Commercial insurance rates fell 6% and property rates 12%, a headwind to brokerage commissions. Marsh is countering with AI tools like Risk Companion and new offerings such as Archer, which add recurring service revenue and broaden its mix.

    It captures the main negative force on pricing and the company's response.

  • Analysts see 2026 earnings up 7.1% Zacks notes rising 2026 earnings estimates, a $5.5 billion capital deployment plan and management consulting growing 13.4% organically, its fastest in over two years. Upward revisions and expected Q3 beat support the stock.

    Analyst estimate momentum and capital plans are a key forward-looking driver.